Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Levonorgestrel
Drug ID BADD_D01281
Description Levonorgestrel (LNG) is a synthetic progestogen similar to [Progesterone] used in contraception and hormone therapy.[A181988,T659] Also known as Plan B, it is used as a single agent in emergency contraception, and as a hormonal contraceptive released from an intrauterine device, commonly referred to as an IUD. Some of these devices are known as Jaydess, Kyleena, and Mirena. A subdermal implant of levonorgestrel that slowly releases the hormone over a long-term period is also available.[L7823] In addition to the above uses, levonorgestrel is used as a component of long-term combination contraceptives.[A181991,L7760,L7778] Globally, levonorgestrel is the most commonly used emergency contraceptive. It was initially granted FDA approval in 1982 and was the first emergency contraceptive containing only progesterone, showing high levels of efficacy and a lack of estrogenic adverse effects when compared to older emergency contraceptive regimens.[A181976,A181994,L7760]
Indications and Usage For the treatment of menopausal and postmenopausal disorders and alone or in combination with other hormones as an oral contraceptive.
Marketing Status Prescription; OTC; Discontinued
ATC Code G03AC03; G03AD01
DrugBank ID DB00367
KEGG ID D00950
MeSH ID D016912
PubChem ID 13109
TTD Drug ID D0BA9U
NDC Product Code 50419-424; 73302-911; 22552-0047; 43386-622; 45541-1244; 51660-723; 12866-1010; 50419-422; 63190-0660; 63190-0130; 45541-1174; 65129-2003; 50090-1141; 62756-720; 58602-721; 16714-809; 50419-423; 66499-0018; 69536-162; 69536-146; 40032-622; 71205-361; 57297-852; 0113-2003; 65089-0036; 68071-4247; 58602-712; 0536-1142; 68071-4294; 64122-605; 44132-004; 50090-3830; 68180-853; 69536-200; 51508-012; 69536-103; 58602-841; 59057-002; 53104-7669; 62756-718; 62756-723; 69953-515; 68180-852; 70700-164; 69536-133; 71205-120; 59057-001; 50102-211; 0023-5858; 69953-616; 63190-0850; 68071-4126; 44132-012
Synonyms Levonorgestrel | l-Norgestrel | l Norgestrel | 18,19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)- | D-Norgestrel | D Norgestrel | Microval | duofem | Microlut | Mirena | Norgeston | Norplant-2 | Norplant 2 | Norplant2 | NorLevo | Norplant | Plan B | Vikela | Cerazet | Capronor
Chemical Information
Molecular Formula C21H28O2
CAS Registry Number 797-63-7
SMILES CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Asthenopia06.01.01.0020.002085%Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Atelectasis22.01.02.001--
Atrial fibrillation02.03.03.002--
Atrial septal defect03.07.02.002; 02.04.02.009--Not Available
Atrophic vulvovaginitis21.02.01.0030.002085%Not Available
Attention deficit/hyperactivity disorder19.21.04.001--Not Available
Auditory disorder04.02.03.0020.002085%Not Available
Autoimmune hepatitis10.04.09.001; 09.01.07.019--Not Available
Back pain15.03.04.0050.513832%
Bartholin's cyst21.08.03.001; 16.04.04.0030.003127%Not Available
Basedow's disease10.04.08.004; 06.09.04.003; 05.02.02.0030.004169%Not Available
Benign breast neoplasm21.05.01.009; 16.14.01.0050.003127%Not Available
Benign hepatic neoplasm16.06.01.001; 09.04.01.0010.002085%Not Available
Benign hydatidiform mole21.07.02.006; 18.05.03.001; 16.04.01.0020.010423%Not Available
Benign intracranial hypertension17.07.02.0010.132366%Not Available
Bile duct stone09.02.02.0030.002085%Not Available
Bipolar I disorder19.16.01.0020.002085%Not Available
Bladder pain20.02.02.0010.007296%Not Available
Blighted ovum18.01.03.0010.006254%Not Available
Blindness17.17.01.003; 06.02.02.0010.149043%Not Available
Blindness transient17.17.01.004; 06.02.02.0020.012507%Not Available
Blindness unilateral17.17.01.016; 06.02.02.0090.008338%Not Available
Blood bilirubin increased13.03.01.008--
Blood cholesterol increased13.12.01.002--
Blood cortisol increased13.10.09.0060.002085%Not Available
Blood follicle stimulating hormone increased13.10.03.0030.004169%Not Available
Blood glucose decreased13.02.02.001--Not Available
Blood glucose increased13.02.02.002--Not Available
Blood iron decreased13.11.01.0060.005211%Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 39 Pages